Subscribe to Newsletter

Adnan Tufail

The Power List 2018

Adnan Tufail

Consultant Ophthalmologist, Moorfields Eye Hospital; Institute of Ophthalmology, UCL, London, UK

Adnan is the clinical and research lead for AMD at Moorfields, and he’s achieved a lot in that role. He was a co-principal investigator in the seminal ABC Trial that focused on examining bevacizumab for the treatment of neovascular AMD, which had a profound effect on eyecare in the UK: it defined anti-VEGF treatment protocols for wet-AMD therapy within the NHS. He’s also an early pioneer of big data and machine learning in ophthalmology, with numerous publications to his name on that topic to date. He founded an ARVO AI special interest group that grew into an all-day course, and is involved in the validation of machine learning algorithms that are being introduced into the UK for diabetic screening.

Adnan co-leads the €16 million Macustar Consortium, which unites industry and academia to drive dry AMD research, is the clinical lead of the largest-ever UK Medical Research Council grant to develop novel non-VEGF anti-angiogenic therapies, and he’s highly regarded in industry too. He’s initiated various important clinical trials in age-related macular degeneration, including some seminal big data real-world analyses that have revealed a lot of important information about clinical practice today. He is involved in laboratory as well as clinical research into treating a number of rare retinal diseases – and, on top of all that, he’s a gifted surgeon!

Going About Things In The Right Way

Part of the Power List 2018

100 reasons to be proud

This is the third time we have tried to map the Top 100 most influential people in the world of ophthalmology. The list includes surgeons, scientists, engineers, CEOs and more, and each one of them has been voted for by you, our readers.

Go to The Power List 2018

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine



The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: